Skip to main content
SpringerLink
Log in

Terbinafine: a cost-effective first-line option for superficial dermatophytosis and onychomycosis

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Davis R, Balfour JA. Terbinafine: a pharmacoeconomic evaluation of its use in superficial fungal infections. PharmacoEconomics 1995 Sep; 8(3): 253–69

    Article  PubMed  CAS  Google Scholar 

  2. Roberts DT. Oral therapeutic agents in fungal nail disease. J Am Acad Dermatol 1994; 31 Suppl.: S78–81

    Article  PubMed  CAS  Google Scholar 

  3. Midgley G, Moore MK, Cook JC, et al. Mycology of nail disorders. J Am Acad Dermatol 1994; 31 Suppl.: S68–74

    Article  PubMed  CAS  Google Scholar 

  4. Lubeck DP, Patrick DL, McNulty P, et al. Quality of life of persons with onychomycosis. Qual Life Res 1993 Oct; 2: 341–8

    Article  PubMed  CAS  Google Scholar 

  5. British National Formulary No. 29. London: The Pharmaceutical Press, 1995

  6. Physicians GenRx. St. Louis, Missouri: Mosby-Year Book, Inc., 1995

  7. Evans EGV, Shah JM, Joshipura RC. One-week treatment of tinea corporis and tinea cruris with terbinafine (Lamisil) 1% cream: a placebo-controlled study. J Dermatol Treat 1992; 3: 181–4

    Article  Google Scholar 

  8. Evans EGV, James IGV, Joshipura RC. Two-week treatment of tinea pedis with terbinafine (Lamisil) 1% cream: a placebo controlled study. J Dermatol Treat 1991; 2: 95–7

    Article  Google Scholar 

  9. Evans EG, Dodman B, Williamson DM, et al. Comparison of terbinafine and clotrimazole in treating tinea pedis. BMJ 1993 Sep 11; 307: 645–7

    Article  PubMed  CAS  Google Scholar 

  10. Elewski B, Bergstresser PR, Hanifin J, et al. Long-term outcome of patients with interdigital tinea pedis treated with terbinafine or clotrimazole. J Am Acad Dermatol 1995; 32: 290–2

    Article  PubMed  CAS  Google Scholar 

  11. Balfour JA, Faulds D. Terbinafine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses [published erratum appears in Drugs 1992 May;43 (5): 699]. Drugs 1992 Feb; 43: 259–84

    Article  PubMed  CAS  Google Scholar 

  12. Evans EGV, Seaman RAJ, James IGV. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections. Br J Dermatol 1994 Jan; 130: 83–7

    Article  PubMed  CAS  Google Scholar 

  13. Hay RJ. Treatment of dermatomycoses and onychomycoses-state of the art. Clin Exp Dermatol 1992; 17 Suppl. 1: 2–5

    Article  PubMed  Google Scholar 

  14. J&J’s Sporanox heals nail fungus after 12-week treatment. FDC Reports — Pink Sheet 1995 Oct 23; 57(43): T&G2-3

    Google Scholar 

  15. Bräutigam M, Nolting S, Schopf RE, et al. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Br Med J 1995 Oct 7; 311: 919–22

    Article  Google Scholar 

  16. Chren M-M, Landefeld CS. A cost analysis of topical drug regimens for dermatophyte infections. JAMA 1994 Dec 28; 272: 1922–5

    Article  PubMed  CAS  Google Scholar 

  17. Shear NH, Einarson TR, Arikian SR, et al. Pharmacoeconomic analysis of topical treatments for tinea infections. PharmacoEconomics 1995; 7: 251–67

    Article  PubMed  CAS  Google Scholar 

  18. Shear NH, Einarson TR, Arikian SR, et al. Pharmacoeconomic analysis of topical treatments for tinea infections. A comparative analysis in Austria, Germany and Switzerland [in German]. Z Allgemeinmed 1995; 71: 1055–60

    Google Scholar 

  19. Arikian SR, Einarson TR, Kobelt-Nguyen G, et al. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group. Br J Dermatol 1994 Apr; 130 Suppl. 43: 35–44

    Article  PubMed  Google Scholar 

  20. Goodfield MJD, Bosanquet N, Evans EGV, et al. Cost effective clinical management of onychomycosis. Br J Med Econ 1994; 7: 15–23

    Google Scholar 

  21. Denning DW, Evans EGV, Kibbler CC, et al. Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology). BMJ 1995 Nov 11; 311: 1277–81

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terbinafine: a cost-effective first-line option for superficial dermatophytosis and onychomycosis. Drugs Ther. Perspect 7, 1–5 (1996). https://doi.org/10.2165/00042310-199607010-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607010-00001

Keywords

Search

Navigation